Brief description of study
The primary objective of the post-marketing study is to collect safety and effectiveness data for 5 years on subjects treated with Prolieve.
The collection of 5-year safety information will be used to evaluate the occurrence of any long-term side effects from the treatment.
The collection of long-term effectiveness data on subjects treated with Prolieve will provide information on the long-term effects of treatment and time to re- treatment (any treatment initiated for BPH since Prolieve'" treatment, including a second treatment with Prolieve").
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Benign prostatic hypertrophy
Age: Between 18 - 100 Years